The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(2-Phenyl-quinazolin-4-ylamino)-benzoic acid methyl ester ID: ALA120099
PubChem CID: 1183964
Max Phase: Preclinical
Molecular Formula: C22H17N3O2
Molecular Weight: 355.40
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COC(=O)c1ccc(Nc2nc(-c3ccccc3)nc3ccccc23)cc1
Standard InChI: InChI=1S/C22H17N3O2/c1-27-22(26)16-11-13-17(14-12-16)23-21-18-9-5-6-10-19(18)24-20(25-21)15-7-3-2-4-8-15/h2-14H,1H3,(H,23,24,25)
Standard InChI Key: YNJLEXNLBZQNTP-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
-0.5500 -2.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0333 -2.4292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0333 -3.0375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5500 -3.3375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0708 -2.4375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0708 -3.0375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5583 -1.5292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.5167 -0.3250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0000 -0.6292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4917 -3.3375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5125 0.2750 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.0333 -1.2292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0042 -1.2292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4750 -0.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0375 -0.6167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.0458 -0.6375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4792 -1.5292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5833 -2.1375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5833 -3.3375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4917 -3.9375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0042 -3.0292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0417 -1.2167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1083 -2.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1083 -3.0375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0125 -4.2292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5292 -3.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5292 -3.9292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 6 1 0
5 1 1 0
6 5 1 0
7 1 1 0
8 9 1 0
9 13 2 0
10 3 1 0
11 8 2 0
12 7 1 0
13 17 1 0
14 16 2 0
15 8 1 0
16 12 1 0
17 12 2 0
18 5 2 0
19 6 2 0
20 10 2 0
21 10 1 0
22 15 1 0
23 18 1 0
24 23 2 0
25 20 1 0
26 21 2 0
27 26 1 0
4 3 2 0
14 9 1 0
19 24 1 0
25 27 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 355.40Molecular Weight (Monoisotopic): 355.1321AlogP: 4.83#Rotatable Bonds: 4Polar Surface Area: 64.11Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 4.18CX LogP: 5.77CX LogD: 5.77Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.53Np Likeness Score: -1.23
References 1. Lee SJ, Konishi Y, Yu DT, Miskowski TA, Riviello CM, Macina OT, Frierson MR, Kondo K, Sugitani M, Sircar JC.. (1995) Discovery of potent cyclic GMP phosphodiesterase inhibitors. 2-Pyridyl- and 2-imidazolylquinazolines possessing cyclic GMP phosphodiesterase and thromboxane synthesis inhibitory activities., 38 (18): [PMID:7658441 ] [10.1021/jm00018a014 ] 2. Krapf MK, Wiese M.. (2016) Synthesis and Biological Evaluation of 4-Anilino-quinazolines and -quinolines as Inhibitors of Breast Cancer Resistance Protein (ABCG2)., 59 (11): [PMID:27148793 ] [10.1021/acs.jmedchem.6b00330 ]